Skip to content

Clinical trials

Hypercholesterolemia trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypercholesterolemia Country / region: Taiwan Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20072
20082
20101
20112
20137
20141
20151
20161
20182
20212
20221
20236
20244
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Active, not recruiting6
Recruiting4
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen7
Merck Sharp & Dohme LLC5
Novartis Pharmaceuticals5
Chang Gung Memorial Hospital4
Kastle Therapeutics, LLC3
Sanofi3
AstraZeneca2
Nang Kuang Pharmaceutical Co., Ltd.1
National Taiwan Sport University1
National Taiwan University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypercholesterolemia38
Hyperlipidemias10
Dyslipidemias9
Cardiovascular Diseases6
Hyperlipoproteinemia Type II6
Homozygous Familial Hypercholesterolemia4
Aortic Valve Stenosis2
Atherosclerosis2
Congenital Abnormalities2
Diabetes Mellitus, Type 22

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.